从A2/A2B到B的结果 已故捐赠者移植:一项回顾性研究
Mia A Jose1, Ketan Tamirisa2, Srichandra Pallerla3
1Carroll Medical Academy, Carroll Senior High School, Southlake, USA.
Cureus
|December 11, 2024
概括
A2/A2B到B 已故捐赠者移植 (DDKTs) 显示出优异的一年生存率. 这种手术增加了少数族裔候选人B型血液型的移植机会.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
背景情况:
- 从A2/A2B到B的移植可以改善B血型少数群体候选人的获得.
- 这种移植类型尽管报告成功,但仍未得到充分利用.
研究的目的:
- 调查A2/A2B到B已故供体移植 (DDKTs) 的移植后结果.
主要方法:
- 从2017-2023年对54个A2/A2B到BDDKT进行了回顾性研究.
- 评估接受者/捐赠者的人口统计数据,病史和移植后的结果.
- 评估了一年的移植和患者存活率.
主要成果:
- 一年移植存活率为96.2%;患者存活率为98.1%.
- 一年内血清肌氨酸的平均值为1.4 mg/dL.
- 9.2%的患者出现了延迟的移植功能;5.5%的患者出现了急性排斥.
结论:
- 从A2/A2B到B的DDKT表现出了良好的一年业绩.
- 少数民族候选人从这种移植策略中获得了显著的好处.
相关概念视频
01:24Tissue Transplantation
338
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
338
01:22Bone Marrow Sampling and Transplants
284
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
284